Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-08-28Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls
-
CLINICAL_TRIALS study record update · 2019-08-14A Phase 1 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZSP1273 and the Effect of Food on ZSP1273 Pharmacokinetics in Chinese Healthy Subjects.
-
CLINICAL_TRIALS study record update · 2019-08-14A Phase III, Prospective, Randomized, Open-Labeled, Active-Controlled, Multi-Center Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine, GC FLU, in Adults Aged 20 to 50
-
CLINICAL_TRIALS study record update · 2019-08-13Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)
-
CLINICAL_TRIALS study record update · 2019-08-07Impact Study of a Rapid Diagnosis of Influenza in the Emergency Medical Service During the 2018-2019 Epidemic Season
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-08-05Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2019-07-26Statin Therapy in Acute Influenza
-
CLINICAL_TRIALS study record update · 2019-07-08Randomized, Double-blind, Placebo-controlled Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza.
-
CLINICAL_TRIALS study record update · 2019-07-05A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity of Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle
-
CLINICAL_TRIALS study record update · 2019-06-19Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
-
CLINICAL_TRIALS study record update · 2019-06-03An Observer-blind, Dose Ranging Safety and Immunogenicity Study of GSK Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
-
CLINICAL_TRIALS study record update · 2019-05-15An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe
-
CLINICAL_TRIALS study record update · 2019-05-07A Randomised, Controlled, Blinded Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian H5 Influenza Vaccine in Adults
-
CLINICAL_TRIALS study record update · 2019-05-06An Open, Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years
-
CLINICAL_TRIALS study record update · 2019-05-01Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model
-
CLINICAL_TRIALS study record update · 2019-04-26Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2019-04-25Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients
-
CLINICAL_TRIALS study record update · 2019-04-24A Phase III, Randomized, Observer Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Repeated Exposure to Either the Same or Alternate Type of Vaccine, Adjuvanted or Non-adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV or QIV), Administered to Subjects Previously Vaccinated in Trial V118_05 (NCT01964989)
-
CLINICAL_TRIALS study record update · 2019-04-22Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/Mallard/Netherlands/00/95 (H7N3) Influenza Vaccine
-
CLINICAL_TRIALS study record update · 2019-04-19A Phase 3 Double Blinded, Randomized, Placebo- Controlled Study to Examine the Safety and Immunogenicity of a Seasonal Trivalent Split Inactivated Influenza Vaccine Produced by Institute Torlak in 18-65 Year Old Volunteers in Serbia
-
CLINICAL_TRIALS study record update · 2019-04-12Randomised, Double-Blind, Placebo-Controlled, Phase IIa Study in Healthy Volunteers to Evaluate the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Model
-
CLINICAL_TRIALS study record update · 2019-04-11Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX
-
CLINICAL_TRIALS study record update · 2019-04-08A Randomised, Double-blind, Placebo-controlled, Single-centre Phase IIb Trial as Part of the EU-funded UNISEC Project to Assess the Immunogenicity and Safety of Different Formulations and Dosing Regimens of FLU-v Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2019-03-27Evaluation of the RAMP FLU A+B Test Versus Viral Culture Using Clinical Nasal Swab Samples From Patients With Suspected Influenza Infections
-
CLINICAL_TRIALS study record update · 2019-03-25A Phase I Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine